Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

283 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Vasopressin receptor antagonists.
Greenberg A, Verbalis JG. Greenberg A, et al. Among authors: verbalis jg. Kidney Int. 2006 Jun;69(12):2124-30. doi: 10.1038/ Epub 2006 May 3. Kidney Int. 2006. PMID: 16672911 Review.
The treatment of severe hyponatremia.
Gross P, Reimann D, Neidel J, Döke C, Prospert F, Decaux G, Verbalis J, Schrier RW. Gross P, et al. Kidney Int Suppl. 1998 Feb;64:S6-11. Kidney Int Suppl. 1998. PMID: 9475480
Tolvaptan and Neurocognitive Function in Mild to Moderate Chronic Hyponatremia: A Randomized Trial (INSIGHT).
Verbalis JG, Ellison H, Hobart M, Krasa H, Ouyang J, Czerwiec FS; Investigation of the Neurocognitive Impact of Sodium Improvement in Geriatric Hyponatremia: Efficacy and Safety of Tolvaptan (INSIGHT) Investigators. Verbalis JG, et al. Am J Kidney Dis. 2016 Jun;67(6):893-901. doi: 10.1053/j.ajkd.2015.12.024. Epub 2016 Feb 11. Am J Kidney Dis. 2016. PMID: 26874645 Clinical Trial.
Oral tolvaptan is safe and effective in chronic hyponatremia.
Berl T, Quittnat-Pelletier F, Verbalis JG, Schrier RW, Bichet DG, Ouyang J, Czerwiec FS; SALTWATER Investigators. Berl T, et al. Among authors: verbalis jg. J Am Soc Nephrol. 2010 Apr;21(4):705-12. doi: 10.1681/ASN.2009080857. Epub 2010 Feb 25. J Am Soc Nephrol. 2010. PMID: 20185637 Free PMC article. Clinical Trial.
283 results